Data on the molecular makeup and drug sensitivity of hundreds of patient samples could accelerate progress against the aggressive blood cancer acute myeloid leukemia.
from All Top News -- ScienceDaily https://ift.tt/2yLgsf1
from All Top News -- ScienceDaily https://ift.tt/2yLgsf1
Comments
Post a Comment